A Memorandum of Understanding was signed today by the President of the Government of the Republic of Serbia, Ana Brnabi, and the Director of the Pharmaceutical Company "Merck Sharp and Dohme," Cyril Siver. This agreement is crucial for the future research center BIO4 campus in Serbia.
"MSD" is a new company that has joined the BIO4 Campus!
11 May 2023
The Prime Minister stated that our nation wants to make Serbia one of the most significant centers in Europe at the time the memorandum of understanding referred to the MSD company's participation in the BIO4 campus. She also noted that this is a significant date for the future BIO4 Campus and for Serbia as a significant biotechnological research and development destination.
As the prime minister stated, the company "MSD" has been very active in Serbia since 1996 and collaborates with the Republic Health Insurance Fund to give the most cutting-edge and cutting-edge therapies for the treatment of our patients, especially the most challenging oncology patients.
According to Shiver, the agreed contract would enable the company "MSD," which specializes with offering patients cutting-edge care and treatment choices, to work on a research project at the BIO4 Campus.
-
21 December 2023The 7th Advanced Technology Forum Held at NTP Nis
-
6 December 2023How Artificial Intelligence Impacts Education?
-
20 November 2023Opportunities for Applying Artificial Intelligence in Tourism
